Search Results

You searched for : Barda  

CDC says 3 feet of distance enough for schoolers

New school safety guidelines from CDC...
Mar 20

FUJIFILM Diosynth Biotechnologies begins production of two COVID-19 vaccines

FUJIFILM Diosynth Biotechnologies announced that production has begun in Texas on two different COVID-19 vaccine candidates with support from the U.S. government...
Jan 19

Ortho's VITROS® SARS-CoV-2 Antigen Test for Accurate, Mass-Scale COVID-19 Testing is the First High-Volume Test to Receive FDA Emergency Use Authorization

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics, today announced that its VITROS® SARS-CoV-2 Antigen Test, designed to detect active infection, ...
Jan 13

Regeneron Announces U.S. Government Agreement to Purchase Additional COVID-19 Antibody Cocktail Doses

The new agreement covers 1.25 million additional doses of the casirivimab and imdevimab antibody cocktail, bringing the total potential U.S. supply to over ...
Jan 13

RedHill's phase 2/3 COVID-19 study of opaganib passes second DSMB with unanimous recommendation to continue

Opaganib potentially minimizes likelihood of resistance due to viral mutations by targeting a human cell component involved in viral replication ...
Dec 22

The RedHill Phase II / III candidate opaganib reduces ARDS-related blood clotting in the preclinical model in COVID-19 patients

The results also show that opaganib inhibits SARS-CoV-2 virus replication and proinflammatory markers in relevant preclinical models ...
Dec 17

Moderna announces amendment to supply agreement of COVID vaccine with the ministry of health of Israel

This agreement will support the ongoing efforts by the Ministry to secure early access to a COVID-19 vaccine for the people of Israel...
Dec 05

Regeneron's REGEN-COV2 is first antibody cocktail for COVID-19 to receive US FDA emergency use authorization

The clinical evidence from Regeneron's outpatient trial suggests that monoclonal antibodies such as REGEN-COV2 have the greatest benefit when given early after diagnosis ...
Nov 23

RedHill announces DSMB unanimous recommendation to continue COVID-19 opaganib phase 2/3 study

The independent, pre-programmed DSMB unanimously recommends the continuation of the global Phase 2/3 study of orally administered opaganib in severe COVID-19 pneumonia...
Nov 23

European Commission approves Supemtek® (quadrivalent recombinant influenza vaccine) for the prevention of influenza in adults aged 18 years and older

The European Commission has granted marketing authorization for Supemtek®, a quadrivalent (four-strain) recombinant influenza vaccine, for the prevention of influenza in adults aged 18 ...
Nov 20

Moderna Announces Supply Agreement with United Kingdom Government to Supply mRNA Vaccine Against COVID-19

This agreement comes as the UK continues its efforts to secure access to safe and effective COVID-19 vaccines...
Nov 19

Regeneron’s Antibody cocktail REGN-EB3 (Inmazeb) is first FDA-Approved treatment for Ebola

First FDA approved antibody treatment for Ebola...
Oct 19

Trump Administration Expands Collaboration with AstraZeneca to Develop and Manufacture an Investigational Monoclonal Antibody to Prevent COVID-19

The goal of AstraZeneca's partnership with the U.S. Government is to develop a monoclonal antibody cocktail that can help prevent infection....
Oct 10

COVID-19 AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials

The combination of two LAABs is also designed to reduce the risk of resistance developed by the SARS-CoV-2 virus....
Oct 09

COVID-19 AntiBody (LAAB) combination AZD7442 rapidly advances into Phase III clinical trials

The combination of two LAABs is also designed to reduce the risk of resistance developed by the SARS-CoV-2 virus....
Oct 09

NIH RADx initiative advances six new COVID-19 testing technologies

...
Oct 07

Regeneron Pharma announced, result of Phase 1/2/3 trial of antibody cocktail REGN-COV2

Regenerons REGN-COV2 antibody cocktail reduced viral levels and improved symptoms in non-hospitalized COVID-19 patients...
Oct 02

Veeva and Bioforum partner with RedHill Biopharma to maximize Opaganib Phase 2/3 COVID-19 Clinical Data

Veeva Vault CDMS and Bioforum selected to optimize clinical data management for RedHill’s global Phase 2/3 clinical trial ...
Sep 25

CHMP recommends approval of Supemtek for the prevention of influenza in adults aged 18 and above

CHMP has adopted a positive opinion for Supemtek for active immunization for the prevention of influenza in adults...
Sep 23

Johnson & Johnson initiates phase 3 clinical trial for COVID-19 vaccine Candidate

The Company is committed to bringing an affordable vaccine to the public on a not-for-profit basis for emergency pandemic use...
Sep 23

Vaxart announces FDA clearance of IND application for oral COVID-19 Vaccine

Oral Covid vaccine gains ground...
Sep 18

Vaccine nationalism puts lives at risk says European Union chief

In her first annual State of the European Union address, Ursula von der Leyen said the coronavirus pandemic ...
Sep 17

AstraZeneca to start Phase 3 trials of COVID vaccine in United States

AstraZeneca closer to COVID vaccine as 3rd phase trial starts...
Sep 01

FUJIFILM to support COVID-19 vaccine candidate manufacturing

FUJIFILM Diosynth Biotechnologies will support COVID-19 vaccine candidate manufacturing, as part of Operation Warp Speed, a U.S. government program...
Jul 31

BD partners with U.S. Government for Mass Vaccination campaign

...
Jul 17

25 Matching result(s) found!

-Advertisements-



Trending Now

The Value of Risk Communication in Public HealthOctober 08, 2026
What Makes a Reliable Health Screening Programme?October 08, 2026
How Language Access Can Improve Patient Communication in Indian HealthcareOctober 07, 2026
Why Health Literacy Matters in Preventive HealthcareOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
Improving Follow-Up After Diagnostic Testing: Where Systems Commonly Break DownOctober 07, 2026
How Community Health Workers Support Preventive Care DeliveryOctober 07, 2026
AI in India's Emergency Departments: Reducing Diagnostic DelaysOctober 06, 2026
AI and Patient Consent in India: Who Is Responsible?October 06, 2026
Wearable Technology in Pregnancy: Benefits and LimitsOctober 06, 2026
Remote Monitoring for High-Risk Pregnancies in IndiaOctober 06, 2026
Fortis Escorts Faridabad Launches ‘Sehat Express’ Mobile Bus for Accessible Doorstep Cancer Screening in association with Faridabad Industries Association Charitable Society and Rotary Club FaridabadOctober 05, 2026
Advanced Thrombectomy Saves 60-Year-Old Woman After Severe Heart Attack at KIMS SaveeraOctober 05, 2026
Constipation, Bloating and Long Sitting Hours: Doctors at RG Hospitals Delhi Warn Urban Professionals Not to Ignore Gut ProblemsOctober 05, 2026
Fermenta – Centre of Excellence for Food Fortification Inaugurated at NIFTEM-T, ThanjavurOctober 05, 2026
Alzheimer’s Dementia: Recognising the Signs, Diagnosing Earlier and Changing the Future of Brain HealthOctober 05, 2026
Man Matters Hairfall Case Study 2026: 7 Lakh+ Consultations Reveal How Hair Loss Changes With AgeOctober 05, 2026
Medication Reconciliation: A System-Level Step for Safer Transitions of CareOctober 05, 2026
The Role of Clinical Pharmacists in Safer Medication UseOctober 05, 2026
Nanavati Max Hospital Hosts Max Cancer Congress 2026, Bringing Together Oncology Experts to Explore the Future of Cancer Care October 01, 2026